Lu Hui - Aloe vera

Professional Data
 Pin Yin
Lu Hui
 
 Latin
Aloe
 Introduction Back to Top
Aloe is the dried concentrated matter obtained from the juice of the leaf of Aloe barbadensis Miller, Aloe ferox Miller or other species of the same genus. Aloe barbadensis is habitually known as "Old Aloes"and Aloe ferox is known as "New Aloes".

 Western medical Back to Top
lu hui is indicated in the treatment of constipation, hepatitis, various skin diseases and anti-ageing.

 Eastern medical Back to Top
  • Pattern: Relaxes bowels, clears the Liver, kills parasites.
  • Properties: Bitter, cold.
  • Channels entered: Liver, Heart and Spleen.
 Chemical constituents Back to Top
The main ingredients of lu hui are alon and aloe-emodin.

 Pharmacological actions Back to Top
Laxative effect

lu lui had the strongest stimulative effect in all laxatives of rheochrysin, it could cause obvious abdominal pain and pelvic congestion. In severe cases, it could result in nephritis.

Treating trauma

lu hui could promote the heal of trauma. Its extract or ointment had slight protective effect on local X-radiation in mcie.

Anti-cancer effect

1:500 alcohol infusion of lu hui could in vivo inhibit the growth of S180 and ehrlich carcinoma.

Anti-leukaemic and anti-mutagenic effects of di(2-ethylhexyl)phthalate isolated from Aloe vera Linne.

Extracts of Aloe vera Linne have been found to exhibit cytotoxicity against human tumour cell lines. This study examines the anti-tumour effects of di(2-ethylhexyl)phthalate (DEHP) isolated from Aloe vera Linne, in human and animal cell lines. Its anti-mutagenic effects were examined using Salmonella typhimurium TA98 and TA100 strains. Growth inhibition was specifically exerted by DEHP against three leukaemic cell lines at concentrations below 100 microg mL(-1). At 100 microg mL(-1) DEHP, K562, HL60 and U937 leukaemic cell lines showed growth inhibition of 95, 97 and 95%, respectively. DEHP exhibited an inhibitory activity of 74, 83 and 81%, respectively, in K562, HL60 and U937 cell lines at a concentration of 10 microg mL(-1). At a concentration of 1 microg mL(-1), DEHP exerted an inhibitory activity of 50, 51 and 52%, respectively, in K562, HL60 and U937. In a normal cell line, MDBK, DEHP exerted 30% growth inhibition at a concentration of 100 microg mL(-1), and showed no inhibitory activity at concentrations below 50 microg mL(-1). It was found that DEHP exerted anti-mutagenic activity in the Salmonella mutation assay. The number of mutant colonies of Salmonella typhimurium strain TA98 upon exposure to AF-2 (0.2 microg/plate) decreased in a concentration-dependent manner in the presence of different DEHP concentrations (decreasing to 90.4, 83.9, 75.4, 69.6 and 46.9%, respectively, for DEHP concentrations of 100, 50, 10, 5 and 1 microg/plate). In the case of Salmonella typhimurium strain TA100, DEHP reduced AF-2-induced mutagenicity at 1, 5, 10, 50 and 100 microg/plate to 57.4, 77.5, 80.0, 89.0 and 91.5%, respectively. The isolated compound from Aloe vera Linne, DEHP, was considered to be the active principle responsible for anti-leukaemic and anti-mutagenic effects in-vitro.

--Lee KH, Kim JH, Lim DS, Kim CH. J Pharm Pharmacol. 2000 May; 52(5): 593-8.

Others

1:500 extract of lu hui had inhibitory effect on isolated toad's hearts. Water infusion could inhibit some dermatomyces in vitro to different degrees.

 Clinical Studies Back to Top
Chronic hepatits

Lu Hui Injection, each ml containing 0.1g crude drug, 4ml i.m., 2 months as a course of treatment. 38 cases were cured and the therapeutic effect was 86.8%.

SLE

lu hui was made into injection each ml of which contained 2g crude drug, 2ml, i.m., once daily, 30 days as a course of treatment with an interval of 7 days. In the second course, 4ml, i.m. once daily. 18 cases were treated, and 9 were markedly effective, 7 improved, 2 ineffective.

Syndromes of Excess Fire of the Liver and Gallbladder

Dizziness, headache, tinnitus, deafness, irritability and constipation were treated with Dang Gui Lu Hui Wan, 3~6g daily, 1~2 times daily.

 
 References Back to Top

Except those noted, all references come from Weng Weiliang, et al., Clinical Chinese materia medica, Henan Science & Technology Press, 1998